Beam stock forecast.

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comIt’s difficult to put a positive spin on the current state of the stock market. While 2022’s action has seen moments of relief, for the most part, the trend has been resolutely downbeat, as ...(See BEAM stock forecast on TipRanks) iHeartMedia (IHRT) Let’s switch stations now and tune into something entirely different. iHeartMedia is one of the U.S.’s most prominent audio companies ...Scores. BEAM has an Altman Z-Score of 1.39 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Altman Z-Score. 1.39. Piotroski F-Score. 2. Detailed statistics for Beam Therapeutics Inc. (BEAM) stock, including valuation metrics, financial numbers, share information and more.

(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage diagnostics company that provides care for transplant patients, from finding the right match to follow-on surveillance post-transplant.This is where a guiding hand from Wall Street’s pros comes in handy. The stock experts at banking giant Wells Fargo have identified two names whose share price is down over 50% this year ...

beam stock forecast cnn. ... View the latest BEAM stock quote and chart on… Monday, November 14, 2022 Edit. caffeine light more roast. light roast coffee has more caffeine. Dark Roast Vs Light Roast Coffee November 14, 2022 Edit. nfl picks wallpaper week. sporting news nfl picks week 6.BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I …

Find the latest Altimmune, Inc. (ALT) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Second, Amgen is forecast to post a respectable 4.1% rise in annual sales in 2022. ... A deeply undervalued gene-editing stock. Beam Therapeutics (BEAM 0.68%) ...If implemented, the project could extend online connectivity to thousands of people across Kenya. Google is in talks with telecom operators in Kenya to bring balloon-powered internet to people in rural and remote areas. Through its Project ...Beam Therapeutics Stock Forecast Over the next 52 weeks, Beam Therapeutics has on average historically fallen by 0.2% based on the past 3 years of stock performance. Beam Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%Next reporting date. February 14, 2024. EPS forecast (this quarter) $0.29. Annual revenue (last year) $11.1B. Annual profit (last year) $432.0M. Net profit margin.

3 Wall Street research analysts have issued 12-month price targets for Beam Global's shares. Their BEEM share price targets range from $25.00 to $25.00. On average, they anticipate the company's stock price to reach $25.00 in the next year. This suggests a possible upside of 315.3% from the stock's current price.

Find the latest Verve Therapeutics, Inc. (VERV) stock quote, history, news and other vital information to help you with your stock trading and investing.

According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00.Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an …There are four main types of forecasting methods that financial analysts use to predict future revenues, expenses, and capital costs for a business. While there are a wide range of frequently used quantitative budget forecasting tools, in this article we focus on four main methods: (1) straight-line, (2) moving average, (3) simple linear ...Well, it was only a matter of time. Advertising giant Facebook announced Wednesday that they’re going to begin testing advertising inside virtual reality titles on its Oculus platform soon. The first roll-out is limited enough, with Faceboo...Beam Price Live Data. The live Beam price today is $0.164128 USD with a 24-hour trading volume of $6,003,743 USD. We update our BEAM to USD price in real-time. Beam is up 214.10% in the last 24 hours. The current CoinMarketCap ranking is #654, with a live market cap of $24,315,976 USD. It has a circulating supply of 148,152,520 BEAM coins and a ...

Beam Therapeutics Inc Stock Price History. Beam Therapeutics Inc’s price is currently down 1.73% so far this month. During the month of April, Beam Therapeutics Inc’s stock price has reached a high of $32.82 and a low of $28.62. Over the last year, Beam Therapeutics Inc has hit prices as high as $73.27 and as low as $27.77. Year to date ...A high-level overview of Beam Therapeutics Inc. (BEAM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Analyst Forecast. According to 9 analysts, the average rating for BEAM stock is "Buy." The 12-month stock price forecast is $55.22, which is an increase of …beam stock forecast cnn. ... View the latest BEAM stock quote and chart on… Monday, November 14, 2022 Edit. caffeine light more roast. light roast coffee has more caffeine. Dark Roast Vs Light Roast Coffee November 14, 2022 Edit. nfl picks wallpaper week. sporting news nfl picks week 6.John Evans. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the ...

Lead the world to clean mobility. We believe every person deserves access to safe, clean, reliable transportation. BEAM’s 100% sustainable EV charging solutions are the most rapidly deployed EV charging stations in the world. Fastest Deployed EV Charging In Action.

Beam Global analyst ratings, historical stock prices, earnings estimates & actuals. BEEM updated stock price target summary.Open the BEAM Page at The Online Investor (in a new window) » List of Beverages & Wineries Mergers & Acquisitions in this Slideshow:. 10/3/2012: Acquirer: Crystal Rock Holdings, Inc. (CRVP) Acquiree: Frontenac Crystal Springs and Girard Water Company Merger/Acquisition details: details » 12/14/2012: Acquirer: Coca-Cola FEMSA (KOF) …Find the latest Caribou Biosciences, Inc. (CRBU) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Dutch Bros Inc. (BROS) stock quote, history, news and other vital information to help you with your stock trading and investing.What is the current Price Target and Forecast for Beam Therapeutics (BEAM) Beam Therapeutics (BEAM) (Delayed Data from NSDQ) $29.67 USD +0.20 (0.68%) Updated …Technology Services. Industry. Packaged Software. No executives to display. Corporate headquarters. --, --. Find real-time PLTR - Palantir Technologies Inc stock quotes, company profile, news and ...This morning Beam, an insurtech startup that provides dental coverage to corporate employees, announced that it has closed an $80 million Series E. Mercato-affiliated Traverse led the investment, with Nationwide insurance joining the deal. ...Future criteria checks 2/6. CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum respectively. EPS is expected to grow by 45.6% per annum. Return on equity is forecast to be 2% in 3 years.What is the current Price Target and Forecast for Beam Therapeutics (BEAM) Beam Therapeutics (BEAM) (Delayed Data from NSDQ) $29.67 USD +0.20 (0.68%) Updated …

Beam Global has risen higher in 7 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%. Is Beam Global Stock Undervalued? The current Beam Global [ BEEM] share price is $6.02. The Score for BEEM is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.

The Beam Therapeutics stock forecast is 57.069107374265 USD for 2024 November 25, Monday; and 177.367 USD for 2028 November 25, Saturday with technical analysis. Beam Therapeutics (BEAM) stock price prediction is 57.069107374265 USD.

Oct 28, 2023 · Beam Therapeutics Inc. (BEAM) share price prediction for 2023, 2024, 2025, 2026 and 2027. BEAM one year forecast. Beam Therapeutics stock monthly and weekly forecasts. The Beam Global stock price fell by -1.95% on the last day (Wednesday, 29th Nov 2023) from $6.14 to $6.02. During the last trading day the stock fluctuated 9.27% from a day low at $6.01 to a day high of $6.57. The price has fallen in 7 of the last 10 days and is down by -17.53% for this period. Volume fell on the last day along with the stock ...For Beam Global stock forecast for 2023, 1 predictions are offered for each month of 2023 with average Beam Global stock forecast of $6.11, a high forecast of $6.11, and a low forecast of $6.11. The average Beam Global stock forecast 2023 represents a 4.43% increase from the last price of $5.84999990463257. For Beam Global stock forecast for ...Based on 5 Buys and 4 Holds, the analyst consensus rates the stock a Moderate Buy. Going by the $70.89 average target, the shares will climb ~62% higher in the year ahead. (See BEAM stock forecast) CareDx, Inc (CDNA) The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition.On average, analysts forecast that MSFT's EPS will be $11.13 for 2024, with the lowest EPS forecast at $10.83, and the highest EPS forecast at $11.55. On average, analysts forecast that MSFT's EPS will be $12.71 for 2025, with the lowest EPS forecast at $12.05, and the highest EPS forecast at $13.38.Beam Therapeutics EPS Price Prediction Forecast for 2023 - 2025 - 2030. In the last three years, Beam Therapeutics's EPS has grown, increasing from $-2.49 to $-4.13 – an increase of 65.86%. For the next year, 13 analysts project Beam Therapeutics's EPS to drop by 3.39%, reaching $-3.99. By 2030, professionals believe that Beam Therapeutics's ... The Vanguard Group, Inc. is the second largest shareholder owning 8.3% of common stock, and Arch Venture Partners, L.P. holds about 7.1% of the company stock. Furthermore, CEO John Evans is the ...Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60.Get Beam Therapeutics Inc (BEAM.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.January has now been and gone and turned out to be a nice gift for investors. Battered by 2022’s bear, the tech-heavy Nasdaq, in particular, put in an excellent showing, seeing out the month ~11 ...John Evans. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 and BEAM-102 for the treatment of sickle cell disease beta thalassemia; BEAM-201, an allogeneic chimeric antigen receptor T cell for the ...

Beam Therapeutics (BEAM) Stock Forecast & Price Target $29.47 +1.52 (+5.44%) (As of 11/22/2023 ET) Compare Today's Range $28.24 $29.84 50-Day Range …Get the latest Beam Therapeutics Inc (BEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Track Beam Therapeutics Inc (BEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsInstagram:https://instagram. 500 index admiralis option trading profitableprcoxschwab schd The average Beam Therapeutics stock forecast 2024 represents a 80.7% increase from the last price of $28.5900001525879. For Beam Therapeutics stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Beam Therapeutics stock forecast of $75.12, a high forecast of $83.03, and a low forecast of $61.46.The Beam Therapeutics stock forecast for tomorrow is $ 27.79, which would represent a -6.02% loss compared to the current price. In the next week, the price of BEAM is expected to decrease by -2.93% and hit $ 28.70. As far as the long-term Beam Therapeutics stock forecast is concerned, here’s what our predictions are currently suggesting. trade algo reviewsqqq average return last 10 years Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing ...Track Beam Therapeutics Inc (BEAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors ugi corporation Jun 12, 2022 · Beam Therapeutics Let’s start off in the high-risk, high-reward biotech sector. ... (See IHRT stock forecast on TipRanks) To find good ideas for stocks trading at attractive valuations, visit ... As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.